3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
7
Exenatide
4
Vitamin D
2
Sugars
2
Resistance Training
2
penclomedine
1
licogliflozin
1
exemestane
1
dapagliflozin
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Weight Reduction Programs
1
Therapeutics
1
Testosterone
1
Taxes
1
Tamoxifen
1
TOPS
1
Surveys and Questionnaires
1
Sugammadex
1
Sodium-Glucose Transporter 2 Inhibitors
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Qsymia
1
Progesterone
1
Paclitaxel
1
Observation
1
Nutrition Assessment
1
Naltrexone
1
Methods
1
Letrozole
1
Jogging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Obesity
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts